From: What is the evidence that tau pathology spreads through prion-like propagation?
Pathological change and Tau species implicated | Potential modes of tau toxicity | Selected References |
---|---|---|
Hyperphosphorylation (e.g. soluble monomer/dimer) | Loss Of microtubule-binding (and other) Function(s) (LOF) leading to axonal transport and synaptic defects reflected in mitochondrial clumping, Golgi disruptions and mis-sorting of synaptic proteins. Mis-localisation may also be evident causing Gain Of toxic Function (GOF). Collectively these may be responsible for neuronal dysfunction at early stages of disease. It is possible that a partial LOF is required for, and leads to an eventual GOF | |
Misfolding/aberrant folding and aggregation into small aggregates (e.g. sarkosyl soluble oligomers) | Neuronal dysfunction and neurodegeneration evident in some models in the absence of larger aggregates implying that smaller soluble oligomeric species responsable for these phenotypes | |
Aggregation (into large insoluble oligomers such as granular tau oligomers and filaments including tangles) | Space-occupying lesions resulting in GOF. Toxicity debated because in some models rescue of neuronal dysfunction and degeneration evident despite persistence of larger aggregates. |